[Biological activity of regulatory peptides in model experiments in vitro].
Kozina. L S LS; Arutiunian. A V AV; Stvolinskiĭ. S L SL; Khavinson. V Kh VKh
Key Findings
- Vesugen does not have direct antioxidant activity but can limit lipid peroxidation of human lipoproteins
- It increases the stability of red blood cell membranes against osmotic hemolysis
- It raises baseline intracellular ROS yet reduces neuronal cell death (except epitalon)
Practical Outcomes
- The data suggest vesugen could modestly protect cell membranes and support neuron survival, but because the work is purely in vitro there’s no clear dosage or protocol for humans. Biohackers should view this as an early hint rather than a ready‑to‑use supplement, and await animal or clinical studies before incorporating it into longevity regimens.
Summary
In lab tests, the short peptide vesugen (along with similar peptides) didn’t act like a classic antioxidant, but it helped keep lipids in human blood particles from breaking down and made red blood cells tougher against swelling. It also raised the normal level of reactive oxygen inside cells while actually lowering the number of dead brain cells, hinting it might influence cell death pathways. However, these results are only from cell‑culture experiments, not real‑world human studies.
Abstract
Biological effects of short regulatory peptides, pinealon, vesugen, vilon and epitalon were studied in model experiments in vitro. These peptides were found not to demonstrate direct antioxidant activity but be able to restrict lipid peroxidation of human lipoproteins by modification of their structure. The short peptides increase stability of red blood cell membranes toward osmotic hemolysis. They also elevate the stationary level of intracellular reactive oxygen species and at the same time decrease (all excepting epitalon) percent of dead cells in neuronal population. The suggestion was made that under in vivo conditions, short peptides may participate in apoptosis/necrosis regulation.
Study Information
pubmed
2008